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A b s t r a c t
The quantitative comparison of gene expression represents one of the major 
approaches for the analysis of gene function. Recently, the discovery of 
unknown genes based only upon their expression pattern has become 
possible through the application of various differential cloning methods, 
including subtractive hybridization, differential display, and expressed 
sequence tag analysis. Due to numerous technical and procedural 
limitations, however, none of these technologies is currently capable of 
rapidly identifying differentially regulated transcripts based on multiple 
expression-related criteria. Therefore, an alternative approach was devised 
which allows for the sequential application of numerous selection criteria 
during the initial screening process, thereby enabling the rapid identification 
of transcripts with highly specific expression patterns. Because of its use of 
multiple positive and negative selection steps, this approach is called Boolean 
selection.
One of the first applications of this new approach was the search for novel 
genes associated with the formation and reorganization of neuronal networks 
in the mammalian brain. An ideal model system for this analysis is the 
retinocollicular system of the rat, where numerous aspects of neurite 
outgrowth, axon guidance, synapse formation and reorganization, and 
regulation of neuronal survival can easily be studied. Boolean selection was 
applied for the identification of transcripts preferentially expressed in the 
superior colliculus during late prenatal development as well as after the loss 
of afferent input in the adult animal. An initial analysis of several of these 
selected transcripts revealed that all satisfied at least one selection criterion 
and that over half satisfied both, indicating the usefulness of Boolean 
selection for the rapid identification of differentially regulated genes.
Although additional analysis by in situ hybridization will still be necessary to 
verify the extent of differential expression and to provide information on 
the cellular localization of the transcripts identified so far, it was possible 
with this preliminary screen to gain new insight into some of the molecular 
and cellular activities in the superior colliculus during periods associated
with the formation and reorganization of synaptic connections. Some of the 
identified transcripts encode proteins associated with post-transcriptional 
protein synthesis and modification events, including ribophorin (an essential 
subunit of the protein glycosylation complex oligosaccharyltransferase), 
calnexin (a membrane-associated molecular chaperone of the endoplasmic 
reticulum), and translation initiation factor, which together suggest enhanced 
levels of protein production and secretion. Other transcipts include rSec6  
(part of the protein complex involved in the docking and fusion of synaptic 
vesicles to the plasma membrane) and Fyn (a nonreceptor tyrosine kinase 
found at high concentrations in axonal growth cones and also known be 
involved in synaptic plasticity), Fas-associated protein factor (a recently- 
identified molecule potentially involved in Fas-mediated signal transduction 
during programmed cell death), and a novel member of the EOF 
superfamily of transmembrane growth factors (which presently includes the 
E G F /T G F a  family and the neuregulins). Further analysis of these 
m olecules may provide additional inform ation about the signaling 
mechanisms and cell-cell interactions at work during the establishment and 
modification of neuronal networks.
A CKNO W LEDGM ENTS
The research presented in this thesis was performed at the Max Planck 
Institute for Developmental Biology in Tubingen, Germany under the 
supervision of Prof. Friedrich Bonhoeffer and under the external supervision 
of Dr. Rob Krumlauf of the National Institute for Medical Research in 
London, England.
The first phase of the project, the development of the Boolean selection 
technique, was done in collaboration with Camila V. Esguerra of the Max 
Planck Institute for Developmental Biology. The second phase of the project, 
the application of this technique to the analysis of differential gene expression 
in tlie retinocollicular system of the rat, was done in collaboration with Dr. 
Mathias Bâhr and his colleagues of the Department of Neurology of the 
University of Tübingen.
I would like to thank Elke Hoffmann for her excellent technical assistance 
throughout the second phase of the project. I also thank Dr. Mathias Bâhr for 
his enthusiasm and optimism. In addition, I am indebted to several members 
of his group, past and present, for their surgical support.
Last but not least, I am very grateful to Prof. Friedrich Bonhoeffer for his 
generous support and patience, especially with regard to my numerous, 
diverse projects.
In t r o d u c t i o n
I n t r o d u c t i o n
An effective strategy for the analysis of complex embryological events and 
for the identification of key components involved in regulating these events 
has been the use of genetic screens (Niisslein and Wieschaus, 1980; Horwitz 
et al., 1983; Jürgens et al., 1995; Haffter et al., 1996). This type of 
functional approach has certain limitations, however, because many genes 
have multiple roles throughout development. This limits the effectiveness of 
such screens to the analysis of processes occuring relatively early in 
development, as mutations in genes with essential functions in these early 
processes can often result in such significant perturbations that the 
systematic analysis of subsequent events is not possible. In addition, certain 
genes cannot be identified by genetic screens because of inherent functional 
redundancies or other compensatory mechanisms that come into effect when 
their encoded proteins are missing or nonfunctional, as has been suspected to 
occur for numerous targeted mutations in mice (Shastry, 1994). Finally, 
many developmental processes, especially later events such as the formation 
of functional neural circuits, are difficult to analyze by genetic means 
because of the inefficient screening procedures necessary for the 
determination of phenotype. Large-scale screens are also restricted to very 
few model organisms because of numerous issues regarding generation time, 
fecundity, cost of riiaintainance, and suitability for systematic analysis.
Other functional approaches for the identification of genes with specific 
biological roles include protein purification and expression cloning, yet 
these require the use of sensitive in vitro assays, which are often quite 
difficult or sometimes even impossible to establish for certain biological 
activities and in vivo systems. In addition, these strategies are ineffective 
for the identification of genes that encode the different constituents of 
protein complexes consisting of multiple, independent factors, as they are 
usually limited to the identification of single genes. These disadvantages also 
hold true for descriptive approaches that involve com prehensive 
comparisons of protein expression profiles, such as two-dimensional gel 
electrophoresis and methods based on the differential generation of 
antibodies.
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With the exception of expression cloning and genetic screens that rely on 
insertional mutagenesis strategies, one additional limitation conunon to all 
approaches mentioned above is the additional time required for the actual 
cloning of individual genes after the initial screening effort. In the case of 
protein-based methods, this usually requires the microsequencing of peptides 
for subsequent cDNA cloning steps, which can be an error-prone and 
technically difficult process. In the case of standard genetic screens using 
chemical or radiation-induced mutagenesis, the identification of individual 
mutations can usually only be accomplished by positional cloning, which 
requires relatively detailed genetic map inform ation in addition to 
significant effort even with invertebrates such as D ro so p h ila  or 
Caenorhabditis, which have relatively short generation times. In addition, 
because of the low resolution of the current genetic map and its relatively 
long generation time, it is not yet possible to readily identify mutant genes in 
the zebrafish, which is currently the only vertebrate model organism 
amenable to systematic genetic analysis.
An alternative approach with significant potential for the process of gene 
discovery is one based on the analysis of differential mRNA expression. 
This strategy relies on the fact that specific cellular responses to external and 
internal stimuli are determined by corresponding changes in genetic activity. 
These changes are reflected by alterations in the transcription rates of 
various genes and can therefore be monitered through the quantitative 
examination of messenger RNA populations. There are several different 
methods that have been developed over recent years that employ this 
strategy for the identification of differentially regulated transcripts, albeit 
with varying degrees of efficiency.
Identification of Differentially Regulated Transcripts
Current approaches for the analysis of differential gene expression, 
including subtractive hybridization (Sargent and Dawid, 1983; Hedgewick et 
al., 1984), differential display (Liang and Pardee, 1992), and expressed 
sequence tag (EST) analysis (Okubo et al., 1992), as well as various PCR- 
based procedures such as suppression subtractive hybridization (Diatchenko 
et al., 1996) and representational difference analysis (Hubank and Schatz,
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1994), all have numerous disadvantages that make them inadequate for the 
rapid identification of genes based on multiple expression-related criteria. 
Differential display, also known as mRNA fingerprinting, involves the 
global PCR amplification of mRNA with combinations of arbitrary primers, 
resulting in the generation of amplicons of discrete length which are then 
visualized by polyacylamide gel electrophoresis. Some of the primary 
disadvantages associated with differential display and other, similar 
procedures include ( 1 ) low reproducibility because of an inherent 
susceptibility to minor changes in reaction conditions, (2 ) low sensitivity 
because of an inherent bias for abundantly expressed transcripts, and (3) 
significant requirements in terms of labor and reagent consumption, which 
together preclude the use of these approaches for the targeted identification 
of specific genes. Some o f these points are also true for the analysis o f  
differential gene expression by tag sequencing. This approach involves the 
generation of primary cDNA libraries and the single-pass sequencing of 
several hundred to several thousand randomly chosen clones, allowing the 
subsequent comparison of transcript abundance profiles based on the 
frequencies of different sequences. Because of the significant costs 
associated with this method, and also because of the low sampling depth that 
is due to the limited number of different clones that can be sequenced (given 
the high redundancy of primary cDNA libraries), EST analysis is not an 
option for the rapid identification of tissue-specific or differentially 
regulated transcripts.
One of the main disadvantages associated with subtractive hybridization 
procedures is an inherent procedural limitation that results in the generation 
of cDNA populations that only partially fulfill the original selection criteria. 
This limitation is common to all standard protocols where the enrichment 
process involves physical subtractions using mRNA or cDNA that has the 
original transcript abundance profile of the tissue or cell type from which it 
was isolated. This results in the effective Cot of most moderately-expressed 
to weakly-expressed transcript species remaining well below the values 
needed for the efficient removal these transcripts from the sample that is to 
be enriched for differentially expressed genes. This reduction of only the 
more abundant transcripts results in the relative enrichment of all weakly- 
expressed transcripts, regardless of whether they are common to both 
samples or actually differentially expressed. The subtracted sample is 
therefore only partially made up of differentially expressed transcripts.
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increasing the time and effort needed for the relatively labor-intensive 
secondary screening procedures.
In addition, due to the large number of genes that are differentially 
expressed in different cells or tissues, regardless of whether the difference 
in question is of spatial, temporal, or conditional nature, it is extremely 
difficult to identify the few genes that may encode proteins responsible for 
any specific functional differences between these cells or tissues. Most 
protocols require significant amounts of mRNA and therefore relatively 
large amounts of source material, which usually results in the mRNA sample 
representing the genetic activities of many different cell types. It is for 
these reasons that subtractive cDNA library screens for genes encoding 
defined protein activities, or even for genes directly associated with their 
expression or activity (such as transcription factors, receptors, or 
components of specific signal transduction pathways), have proven 
notoriously ineffective in isolating these genes.
Multiple-Parameter Expression Screens by Boolean Selection
For this reason an alternative approach is proposed which allows for the 
rapid identification of transcripts that fulfill multiple selection criteria. This 
is accomplished by the generation, in parallel, of several highly-enriched 
pools of differentially regulated transcripts by an improved subtractive 
hybridization strategy, and by the subsequent isolation of cDNAs from two 
or more of these enriched pools by the newly-developed rescue 
hybridization procedure. Because of the ability of this approach to 
selectively purify differentially expressed transcripts by the application of 
several positive and negative selection steps, it is designated as Boolean 
selection (see Figure 1). This selection scheme represents the first effective 
method for the rapid cloning of specific genes on the basis of m ultiple  
expression-related criteria.
For example, for the identification of transcripts encoding proteins thought 
to be expressed only in a specific region of the brain (region A) at a specific 
timepoint during development (timepoint X), the Boolean selection strategy 
would initially involve two negative selections achieved by the separate 
subtractive hybridizations ( region A NOT region B} and ( timepoint X NOT
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timepoint Y}. These two subtractions can be abbreviated as {A NOT B) 
and {X NOT Y}. In this case NOT is understood to mean "greater than by 
factor w", where n reflects the stringency of subtraction. Standard 
subtraction approaches would be restricted to the generation and analysis of 
only one of these libraries because of their inherent limitation to negative 
selection schemes, thereby necessitating the subsequent analysis of large 
numbers of clones selected on the basis of only this one parameter (spatial or 
temporal). However, the introduction of a positive selection step, achieved 
by a rescue hybridization that allows for the enrichment of cDNAs common 
to both subtracted pools, enables the rapid selection of those cDNA clones 
that fulfill both criteria {A NOT B) AND {X NOT Y}. With this selection 
scheme it is therefore possible to efficiently identify transcripts with highly 
regulated expression patterns simply through the application of multiple 
expression-based selection criteria.
Formation and Reorganization of Synaptic Connections in the Rat 
Superior Colliculus
An ititial test of the effectiveness of the Boolean selection strategy for the 
identification of differentially regulated transcripts was its use for the 
analysis of gene expression changes associated with periods of synapse 
formation and reorganization in the mammalian brain. An excellent model 
system with which to approach this question is the superior colliculus (SC) 
of the rat, one of the primary targets of retinal ganglion cells (in addition to 
the lateral geniculate nucleus) and the mammalian equivalent of the optic 
tectum of lower vertebrates. The superior colliculus is ideal for the analysis 
of the various molecular mechanisms involved in the establishment of 
neuronal netw orks, in part because of the w ell-characterized, 
topographically ordered projection of retinal ganglion cell axons onto the 
retinorecipient layers of the SC during development (allowing the analysis 
of invariant processes such as the guidance of retinal axons by target-specific 
molecules) and because of the accessibility of the visual system for 
experimental manipulation (allowing the analysis of plastic processes that are 
more dependent upon function, such as activity-dependent synaptic 
strengthening).
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In addition to the normal establishment of synaptic connections during 
development, which is initiated shortly before birth and is largely complete 
within the first three postnatal weeks, there is an artificial reorganization of 
synapses that occurs after eye removal or after axotomy of the optic nerve 
in adult animals (Lund and Lund, 1971a, 1971b). This reorganization takes 
place as the result of the lesion-induced degeneration of retinal axons, which 
leads to the loss of afferent inputs for neurons within the retinorecipient 
layers of the SC. After the loss of optic terminals, the synaptic sites of these 
neurons are vacated and reoccupied by local terminals (Maters, 1977), 
indicating that although retinal fibers are unable to regenerate through the 
optic nerve because of myelin-associated neurite growth inhibitors (Schwab, 
1990), their target neurons are still capable of inducing axonal sprouting and 
reestablishing synapses with these axons. Tliis raises questions as to the 
molecular nature of this response and its relation to events that occur during 
development.
The target-specific factors that are involved in m odulating the 
deafferentation-induced sprouting response are still unknown and may be 
similar to those that regulate the initial formation of synaptic connections 
during development. Recent evidence points to the involvement of insulin­
like growth factor-1 (IGF-1) in stimulating reactive axonal growth in the 
adult hippocampus following the removal of afferent inputs (Guthrie et al.,
1995), yet it is not yet clear what role this factor has during development, 
although additional results also indicate its abiUty to promote the survival of 
both embryonic and adult motoneurons (Neff et al., 1993). Expression of 
IGF-1 and other, perhaps unknown growth and/or trophic factors in the 
superior colliculus during phases of synapse formation and reorganization 
may be involved in the regulation of both axonal outgrowth and the survival 
of presynaptic neurons.
Other mechanisms that are likely to have significant roles during the 
formation of synaptic connections in the superior colliculus include 
in teractions betw een target-specific  chem oattractants and their 
corresponding receptors on the ingrowing axons of afferent neurons (von 
Boxberg et al., 1993). Despite the recent cloning of repulsive factors that 
regulate the guidance of retinal ganglion cell axons (Drescher et al., 1995), 
no attractive guidance molecules have yet been identified in the superior 
colliculus. Recent evidence, however, appears to indicate an upregulation in
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the expression of attractive components in the superior colliculus following 
the lesion-induced loss of afferent inputs (Wizenmann et al., 1993; Bâhr and 
Wizenmann, 1996). Nevertheless, it has not yet been determined whether 
these factors are also expressed during development, raising the possibility 
that this response is associated only with deafferentation. .
In order to identify target-specific molecules involved in the various cellular 
processes associated with synapse formation and reorganization, transcripts 
preferentially expressed in the superior colliculus during late prenatal 
development as well as after the loss of afferent inputs were isolated by 
Boolean selection. The identification of such transcripts may enable the 
elucidation of the cellular responses induced by target-specific factors that 
are expressed by post-synaptic neurons during the form ation and 
reorganization of neuronal networks.
M a t e r i a l s  a n d  M e t h o d s
M a t e r i a l s  a n d  M e t h o d s
Collection of Tissue Samples
Superior colliculi from rat embryos at embryonic day 18 (E l8 ), from  
normal adult rats, and from deafferented adult rats were obtained by 
standard surgical procedures and were immediately frozen in cryotubes in 
liquid nitrogen. Sprague-Dawley rats were used in all cases. For the 
deafferentation of adult rat superior colliculi, adult rats were anaesthetized 
with 1% chloralhydrate (420 mg/kg body weight) and one optic nerve was 
unilaterally transsected intraorbitally immediately behind the eye. The 
contralateral superior colliculus was removed at 2 1  days post-axotomy.
Isolation of poly(A)^ RNA
Polyadenylated RNA was isolated with oligo(dT)25-coupled paramagnetic 
latex microspheres (Dynabeads, Dynal) according to the manufacturer's 
specifications with several modifications. Briefly, for each tissue sample 
200 |il Dynabeads suspension (5 mg/ml Dynabeads, 250 mM Tris-HCl pH 
8.0, 20 mM EDTA, 0.1% Tween 20, 0.02% NaN^) were washed once with, 
and subsequently resuspended in, 200 pi lysis/binding buffer (0.5 M LiCl, 
100 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% LiDS, 5 mM DTT). Frozen 
tissue samples were quickly transferred from cryotubes in liquid nitrogen to 
1.5-ml Eppendorf tubes containing 600 pi lysis/binding buffer and 3 p i 20 
mg/ml Proteinase K (Boehringer Mannheim) and homogenized by drawing 
them several times though successively smaller needles (18-gauge, 23-gauge, 
and 27-gauge) on 3-ml syringes. Any remaining cell debris was pelleted by 
centrifuging the tubes at 4°C in an Eppendorf microcentrifuge at maximum 
speed for 1 minute. The resuspended Dynabeads were added to the 
supernatants and these mixtures were then briefly vortexed and incubated on 
ice for 10 minutes. After concentrating the Dynabeads on a magnetic 
particle concentrator (MPC, Dynal) for 5 minutes, the particles were washed 
several times by resuspension and reconcentration, twice with 0.5 ml 150 
mM LiCl, 10 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.1% LiDS and three 
times with 0.5 ml 150 mM LiCl, 10 mM Tris-HCl pH 8.0, 10 mM EDTA.
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The poly(A)^ RNA was eluted from the Dynabeads by resuspending them in 
80 pi 0.2 mM EDTA pH 8.0, incubating the suspension at 65°C for 5 
minutes, and removing the particles by magnetic concentration.
After spectrophotometrically determining the nucleic acid concentration 
using quartz cuvettes pretreated for 30 minutes with 1:1 concentrated HCl / 
methanol, the poly(A)^ RNA samples were subjected to DNase treatment for 
the removal of any remaining trace amounts of genomic DNA prior to 
cDNA synthesis. The reaction mixture, consisting of 80 pi poly(A)^ RNA 
sample in 0.2 mM EDTA pH 8.0, 10 pi lOX DNase buffer (0.4 M Tris-HCl 
pH 7.5, 60 mM MgClj, 20 mM CaClj), 1 pi 10 mg/ml tRNA (Boehringer 
Mannheim), 2 pi 40 U/pl RNase inhibitor (Boehringer Mannheim), 1 pi of a 
1:10 dilution in IX DNase buffer of 10 U/pl DNase I (Slratagene, La Jolla), 
and 6  pi DEPC-treated dHjO, was incubated at 37°C for 30 minutes, then 
extracted twice with 100 pi 25:24:1 phenol (acidic) / chloroform / isoamyl 
alcohol (Amersham) and once with 100 pi 24:1 choroform / isoamyl alcohol 
(Amersham). The DNase-treated poly(A)^ RNA was recoupled to 100 pi 
fresh Dynabeads in lysis/binding buffer with 0.5 pi 20/mg Proteinase K, and 
was then washed and eluted as described above, with the wash volumes 
reduced to 250 pi and the elution volume to 10 pi.
Synthesis of cDNA and Adaptor Ligation
Synthesis of double-stranded cDNA was carried out with several components 
of the Superscript Plasmid System (Life Technologies) according the 
manufacturer's specifications with several modifications. Briefly, 1.5 pg 
DNase-treated poly(A)^ RNA in 9 pi 0.2 mM EDTA pH 8.0 was combined 
with 2 pi 1 pM random hexadeoxynucleotides (Pharmacia Biotech), 
incubated at 70''C for 10 minutes, then cooled on ice for 2 minutes. To this 
mixture was added 4 pi 5X first-strand buffer (250 mM Tris-HCl pH 7.5, 
375 mM Kcl, 15 mM M gC y, 2 pi 100 mM DTT, and 1 pi 10 mM dNTPs 
(Pharmacia Biotech). After pre-incubating this mixture at 37°C for 2 
minutes, 2 pi 200 U/pl M-MLV RNase H reverse transcriptase (Superscript 
n. Life Technologies) was added and this reaction was incubated at 37°C for 
30 minutes, at 45°C for 20 minutes, and at 50°C for 10 minutes. The 
reaction was then placed on ice and the following components were added: 
91 pi DEPC-treated dHgO, 30 pi 5X second-strand buffer (100 mM Tris-
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HCl pH 6.9, 0.45 M KCl, 23 mM MgCl^, 0.75 mM p-N A D \ 50 mM 
(N H J2SO4), 3 pi 10 mM dNTPs, 4 pi 10 U/pl E. coli DNA polymerase I, 1 
pi 10 U/pl E. coli DNA ligase, and 1 pi 2 U/pl E. coli RNase H (all enzymes 
from Life Technologies). After incubation at 16°C for 2 hours, 2 pi 3 U/pl 
T4 DNA polymerase (New England Biolabs) were added and the reaction 
was kept at 16°C for an additional 5 minutes, after which it was stopped by 
placing it on ice and adding 10 pi 0.5 M EDTA pH 8.0.
The double-stranded cDNA was purified from this reaction mixture by 
adsorbtion to silica-gel microparticles (Qiaex, Qiagen) according to the 
manufacturer's specifications. The cDNA was eluted in 30 pi 10 mM Tris- 
HCl pH 8.0 and divided into 2 15-pl aliquots, one of which was restricted 
with Alu I (AG/CT) and the other with both Alu I and Rsa I (GT/AC) in 30- 
pl reaction volumes with 20 U of each restriction enzyme (New England 
Biolabs) and including 10 mM Bis Tris Propane-HCl pH 7.0, 10 mM MgCl2, 
and 1 mM DTT. Both restriction digests were incubated at 37°C for 4 
hours, after which the restricted DNA was then purified with Qiaex particles 
and eluted in 20 pi 10 mM Tris-HCl pH 8.0.
Synthetic adaptors (Wang and Brown, 1991; Balzer and Baumlein, 1994) 
were generated by anneahng pairs of complementary oligodeoxynucleotides 
(custom synthesis by Pharmacia Biotech) to form two different double­
stranded DNA molecules, each with one blunt end and one four-base non- 
complementary overhang at the other end. One pair, CTCTTG- 
CTTGAATTCGGACTA and pTAGTCCGAATTCAAGCAAGAGCACA. 
annealed to form adaptor R, which included an EcoR I restriction site 
(G/AATTC) near the blunt end, whereas the other pair, AGTTAC- 
ACGTCTAGAATGGCT and pAGCCATTCTAGACGTGTAACTGATA. 
annealed to form adaptor X, which included an Xba I restriction site 
(T/CTAGA) near the blunt end Cp’ represents phosphate). The annealing 
reaction was carried out by combining equimolar amounts of the two 
complementary oligodeoxynucleotides in dH2 0  for a total DNA 
concentration of 1 pg/pl, heating this mixture to 75°C, and allowing it to 
slowly cool to 25 °C over at least 30 minutes.
Adaptors were ligated to the Alu  I and Alu IJRsa I restriction fragments of 
the different cDNA pools according to the following scheme: the X adaptor 
was hgated to the embryonic superior colliculus cDNA pool (Ex) and to one
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of two separate normal adult superior colliculus cDNA pools (Nx), and the 
R adaptor was hgated to the other normal adult superior coUiculus cDNA 
pool ( N r)  and to the deafferented adult superior coUiculus cDNA pool ( D r) .  
The ligation reactions included 10 pi 1 pg/pl adaptor, 20 pi Qiaex-purified 
Alu  I 01  Alu URsa I-restricted cDNA in 10 mM Tris-HCl pH 8.0, 10 pi lOX 
ligation buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl^, 1 mM DTT, 1 mM 
ATP, 25 pg/ml BSA), 5 pi 400 NEB U/pl T4 DNA Ugase (New England 
Biolabs), and 55 pi dHjO, and were incubated at 16°C for 12 hours, after 
which the cDNA was purified by adsorption to siUca-gel membrane spin 
colunms with an exclusion limit for double-stranded DNA of 75 base-pairs 
(Qiaquick PCR Purification Colunms, Qiagen). The purification procedure 
was carried out according the manufacturer's specifications and the cDNA 
was eluted in 50 pi TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA). At tliis 
point the Alu \ and Alu l/Rsa I-restricted cDNA fragments for each pool 
were combined.
Amplification of cDNA Fragments
PCR amplification of the adaptor-ligated cDNA fragments was carried out 
using the 21-mer component of each adaptor as the respective primer (R-21 
and X-21). The PCR reactions consisted of 5 pi purified and adaptor-ligated 
cDNA fragments in TE, 10 pi lOX reaction buffer (0.5 M KCl, 100 mM 
Tris-HCl pH 8 .8 , 15 mM MgCl^, 1% gelatin), 1.5 pi 25 mM dNTPs, 4 p i 25 
mM MgClj, 1 pi 1 pg/pl primer in dHjO, 0.5 pi 5 U/pl Taq DNA 
polymerase (Pharmacia Biotech), and dHjO up to 100 pi. The reactions 
were thermocycled (Omnigene, Hybaid) according to the following 
program: 3 minutes at 95°C, 30 cycles of {15 seconds at 95°C, 30 seconds at 
50°C, 2 minutes at 72°C plus 5 seconds extension per cycle} followed by 10 
minutes at 72®C. The amplified cDNA fragments were purified with Qiagen 
spin colunms as described above and eluted in 50 pi TE. The DNA 
concentration of each sample was determined spectrophotometrically and 
adjusted to 100 ng/pl. Each pool was then reamplified essentially as 
described above, with the modifications that 100 pg cDNA were used as 
template material and that both an unmodified and a biotinylated prim er 
(custom synthesis, Pharmacia Biotech) were used for separate amplification 
reactions for the generation of tracer and driver cDNA, respectively. Each
11
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successive round of reamplification (after each subtraction and rescue 
hybridization) was carried out in the same fashion.
Subtractions and Rescue Hybridizations
Subtractions were carried out by combining 20 pi lOOng/pl biotinylated 
driver cDNA amplicons with 1 pi lOOng/pl unmodified tracer cDNA 
amplicons, incubating this mixture at 95°C for 5 minutes, then adding 20 pi 
2X HB+ buffer (2 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 20 mM 
cetyltrimethylammonium bromide (CTAB, Fluka)) and overlaying this 
mixture with mineral oil and incubating it at 6 8 °C for 16 hours. Driver- 
driver and driver-tracer hybrids were removed from tills mixture by 
transferring the aqueous solution under the mineral oil to an Eppendorf tube 
containing 100 pi 10 mg/ml streptavidinylated Dynabeads (Dynal) washed 
once with, and resuspended in, IX HB^ buffer. This suspension was then 
incubated at 6 8 °C with vigorous shaking (Thermomixer, Eppendorf) for 15 
minutes. The Dynabeads were quickly removed by magnetic concentration 
and the supernatant was transferred to another Eppendorf containing fresh 
Dynabeads, and the procedure was repeated. Aliquots (5 pi) of the final 
supernatant were used directly as templates for successive rounds of PCR 
amplification.
Rescue hybridizations were carried out in essentially the same fashion as the 
subtractions, with the difference that the Dynabeads were saved, combined, 
washed twice with IX HB^ buffer and twice with TE, and finally incubated 
twice for 10 minutes at 95°C in 100 pi TE to elute the captured tracer 
cDNA fragments.
Filter Hybridizations
Slot blot filter membranes (Hybond^, Amersham) were generated with 1 pg 
of each cDNA pool using a vacuum manifold (Life Technologies) according 
the manufacturer's specifications. Hybridizations were performed at 6 8 °C 
for 16 hours in 0.5 M NagHPO^ pH 7.2, 1 mM EDTA, 7% SDS, and 1% 
BSA, and the filters were washed twice at 65°C for 30 minutes with 2X SSC 
and 0.1% SDS and once at 65°C for 30 minutes with O.IX SSC and 0.1%
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SDS. Radioactively labeled hybridization probes were generated by 
randomly primed polymerase extension (T7 Quickprime, Pharmacia) using 
a-^^P dCTP (Amersham). Results were quantified by Phosphorlmager 
(Molecular Dynamics) using the ImageQuant program.
Analysis of Library and Individual Clones
After the final reamplification following the rescue hybridization, 1 pg 
cDNA was restricted (in the case of the EN7 pool with Xba I), purified with 
Qiagen spin columns, and hgated to 100 ng Xba I-restricted, 
dephosphorylated pBluescript KS (Stratagene). This hgation was used to 
transform XL-2 E. coli (Stratagene), which were plated at a density of 300 
ampicillin-resistant colonies per 11-cm square agar plate. DNA midipreps 
(Qiagen) were carried out for 24 randomly picked clones, and the cDNA 
inserts were isolated by restriction with Xba I and agarose gel purification 
with Qiaex particles. These were then used as hybridization probes as 
described above with slot blot filters including 1 pg of each original cDNA 
pool. Those clones exhibiting appropriate differential expression levels 
were sequenced as double-stranded plasmids by dideoxy chain termination 
(Autoread, Pharmacia Biotech) using fluoroscein-labeled SK and KS 
primers (Stratagene, custom synthesis by Pharmacia Biotech) on an 
automated sequencer (ALE, Pharmacia Biotech) according the 
manufacturer's specifications. Sequences were analyzed using GCG 
software (Genetic Computing Group) and database searches performed using 
BLAST algorithms (National Center for Biotechnology Information).
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Negative Selection: An Improved Subtraction Strategy
One of first prerequisites for being able to perform multiple-parameter 
selections for the isolation of transcripts that fulfill numerous expression- 
based criteria was the development of an approach for the highly effective 
removal, or subtraction, of common transcripts (i.e., transcripts present at 
approximately equal levels in two or more samples). As mentioned 
previously, all published subtraction protocols are, however, insufficient in 
this regard because their inherent inability to generate suitably enriched 
cDNA pools representing transcripts that are actually differentially 
regulated. One major reason for this problem is that these methods are 
based on multiple or even single rounds of subtractive hybridization with 
driver cDNA or mRNA that has the original abundance profile of its source 
tissue. Because of the large variation in abundance of individual transcript 
species within any cell or tissue (from lO  ^ to 10-6 for homogeneous cell 
populations, and from IQ-i to IQ-i^ or possibly even much lower for highly 
complex tissues such as the brain), the effective Cot for the rare (or even 
moderately abundant) common transcript species during the subtractive 
hybridization is so low that these are not sufficiently removed. In fact, 
because of the more effective removal of abundant common transcripts (in 
relative terms), the relative abundance of these rarer common transcripts is 
increased, leading to high false positive rates during the subsequent 
screening steps. This problem precludes the use of these subtracted cDNA 
pools for any additional positive selection strategies, which would increase 
the background levels to unacceptable levels.
Nevertheless, one recently reported method that employed multiple rounds 
of subtraction, albeit with limited effectiveness (Wang and Brown, 1991), 
seemed amenable to the extent that several technical and procedural 
modifications could rectify these limitations. Briefly, this procedure 
involves the generation of relatively short, amplifiable cDNA fragments 
flanked by synthetic adaptors created by the fragmentation of full-length 
cDNA with four-base restriction restriction endonucleases and the ligation
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of adaptors, followed by the PCR amplification of the fragments with an 
adaptor-specific primer. In this manner, cDNA pools can be created for 
two samples A and B, where B is then used as the driver cDNA to subtract 
common fragments from A, the tracer cDNA, thereby enriching for A- 
specific fragments. This is done through the restriction endonuclease- 
mediated removal of the adaptor sequences from the driver cDNA, the 
photobiotinylation of these fragments, and the subsequent hybridization of 
an excess of driver cDNA with tracer cDNA under conditions appropriate 
for DNA renaturation. Driver-tracer duplexes are removed after this 
hybridization by several streptavidin incubations and phenol-chloroform 
extractions and the remaining fragments from the tracer cDNA are 
reamplified with the adaptor-specific primer.
This procedure is repeated several times using several different driver 
cDNAs and the following enrichment scheme: both A and B undergo 
subtractions in parallel and in complementary fashion, meaning that B 
driver cDNA is used to enrich for A-specific fragments and A driver cDNA 
is used to enrich for B-specific fragments. After each round of subtraction, 
the subtracted cDNA (denoted as Aq, Ai, A2 . . . or Bq, Bi, B2 . . .) is 
reamplified and used in an additional hybridization with another driver 
cDNA. For example, Bo is the driver that is hybridized with Ac to generate 
A i, which then undergoes the next subtraction with Bi as the driver. The 
rationale for this approach takes into account the relative enrichment of the 
common cDNAs that were originally less abundant, but because of the 
depletion of the more abundant cDNAs during the first subtraction, were 
enriched along with most A-specific cDNAs. Using the original driver Bq 
for the second round of subtraction where A% where is now the tracer would 
only result in the continual depletion of abundant common cDNAs from Ai 
but in the additional enrichment of the common cDNAs that were originally 
less abundant. Because this latter class of cDNAs is similarly enriched in Bi, 
however, it is possible with an appropriate excess of Bi as the driver cDNA 
to achieve their effective depletion from the Ai tracer.
Nevertheless, because this priniciple is not consistently applied throughout 
the enrichment scheme (two additional rounds of subtraction are carried out 
with Ao and Bq as driver cDNAs), this protocol does not achieve the 
complete enrichment of differentially expressed transcripts. Originally tliis 
efficiency was reported to be approximately 40% (Wang and Brown, 1991),
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implying that over half of the cDNA clones of the subtracted library are not 
actually differentially expressed, but independent results point to somewhat 
lower efficiencies of about 10% (A. D. Crawford, unpublished results) or 
even 5% (J. Casal, C. V. Esguerra, and M. Leptin, unpublished results). 
This and other technical limitations precluded the use of this approach in its 
original form for the negative selection strategy and necessitated the 
development of an altered protocol that could overcome these limitations.
Several conceptual and technical changes were therefore introduced which 
allowed the subtractive enrichment of differentially expressed transcripts to 
become significantly more efficient, both in terms of time and with regard 
to the degree of enrichment (see Figure 2). First, driver and tracer cDNAs 
were generated with different adaptor sequences, which eliminated the 
contamination caused by the amplification of trace amounts of driver cDNA 
with unrestricted adaptors remaining in the subtracted sample (Balzer and 
Baumlein, 1994). Second, biotinylated driver cDNA was generated not by 
photobiotinylation, an inefficient, time-consuming procedure, but rather by 
the amplification with primers that had already been biotinylated as part of 
the chemical synthesis process and that had been purified by reverse-phase 
HPLC to insure an effective biotinylation rate of over 99.9% (MWG- 
Biotech GmbH, personal communication). Third, driver-tracer duplexes 
were removed after the hybridization step by capturing them onto 
streptavidinylated paramagnetic latex microspheres (Dynabeads®) rather 
than through repetitive incubations with free streptavidin and phenol- 
chloroform extractions, an improvement that proved to be very effective at 
removing all detectable traces of biotinylated driver cDNA and driver- 
tracer cDNA hybrids (data not shown). Fourth, the driver-tracer 
hybrid iza tion  reactions were carried  out in the presence of 
cetyltrim ethylam m onium  bromide (CTAB), one of several cationic 
detergents that have been shown to increase the rate of DNA renaturation by 
more than 1000-fold (Pontius and Berg, 1991). This allowed the cDNA 
concentrations for these hybridizations to be reduced by 1 0 0 -fold while still 
maintaining an improvement in effective Cot values as compared to the 
original method, thereby significantly increasing the throughput in terms of 
the numbers of hybridizations that could be carried out in parallel.
One final change was an alteration of the hybridization strategy so as to 
insure similar abundance profiles of common cDNA fragments for both
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driver and tracer cDNAs during every hybridization. This was done by 
maintaining the sequential order of driver-tracer matches such that Aq was 
paired with Bq, Ai with Bi, A2 with B2 , and so on (see Figure 3). The 
rationale for this approach was to insure the complete removal of all 
common cDNA fragments from each pool undergoing enrichment for 
differentially regulated transcripts, regardless of their abundance in the 
original sample. An initial measure of the overall effectiveness of this new 
approach can be seen by the complete lack of cross-hybridization between 
two final cDNA pools after several rounds of subtractive hybridization (see 
Figures 4 and 5), indicating that both subtractively enriched cDNA pools 
represent transcripts preferentially expressed in their original source 
materials, which in this case are embryonic superior colliculus and normal 
adult superior colliculus, respectively.
Positive Selection: A Rescue Hybridization Strategy
Given the apparent effectiveness of this new subtractive hybridization 
strategy in generating cDNA pools that were significantly enriched for 
differentially regulated transcripts, as well as the dramatic improvement in 
throughput in terms of the number of subtractions that could be carried out 
in parallel, it was now possible to introduce an additional selection 
mechanism based on positive selection. Because of the large number of 
differentially regulated transcripts in any given system, regardless of the 
experimental parameter involved, additional selection criteria are needed in 
order to restrict the selection process to the identification those transcripts 
that may have some significant role in that system. This is especially 
important when the overall selection and screening process cannot be done 
systematically, as is the case when cDNA clones that remain after an 
enrichment procedure are characterized individually by procedures such as 
Northern analysis, in situ hybridization, or sequencing.
For this reason it was attempted to integrate part of the usual post-selection 
screening process into the original selection procedure. This was achieved 
by adding an additional selection criterion to the enrichment strategy, in this 
case by introducing a positive selection step for the specific isolation of 
cDNA fragments that had been enriched in two separate subtraction 
procedures. By performing a subtractive hybridization in reverse so that it
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functions as a rescue hybridization, it becomes possible to use the driver 
cDNA to capture identical fragments from the tracer cDNA instead to 
remove them. This is useful when the fragments common to two separate 
cDNA pools represent the transcripts of interest, as is the case when two 
independent subtractions are performed to isolate transcripts that fulfill two 
different selection criteria.
Boolean Selection of Differentially Regulated Transcripts in the 
Rat Superior Colliculus
In order to identify transcripts that are associated with the formation and 
reorganization of neuronal networks and which therefore might be 
upregulated in the superior colliculus during development and following the 
loss of afferent inputs, two separate subtractions were carried out in order 
to isolate ( 1) transcripts preferentially expressed in embryonic superior 
colliculus as compared to normal adult colliculus and (2 ) transcripts 
preferentially expressed in deafferented adult superior colliculus as 
compared to normal adult colliculus. After the negative selection process 
(the subtractive hybridizations) had generated cDNA pools enriched for 
differentially regulated transcripts fulfilling these two criteria, the positive 
selection process (the rescue hybridization) then selected those cDNA 
fragments common to both pools which might therefore represent 
transcripts fulfilling both criteria. The rescue hybridization was carried out 
using the deafferentation-specific cDNA pool as the driver and the 
embryonic-specific cDNA pool as the tracer. These selected fragments were 
then reamplified and subsequently cloned into a univeral cloning vector to 
generate the enriched cDNA library EN7.
The effectiveness o f the positive selection procedure was measured by an 
initial expression analysis of 24 clones that were randomly chosen from the 
first low-density plating of the enriched cDNA library (of about 3,000 
clones). For these first 24 clones, the extent of differential expression was 
determined by using the individual cDNA fragments as probes in slot blot 
hybridizations with the original cDNA pools (see Figure 6 ). This cDNA 
Southern procedure is considerably more effective than Northern analysis in 
screening large numbers of independent cDNA clones to verify and quantify 
their differential expression. Although not as direct as Northern analysis
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and therefore potentially prone to artifacts such as the nonlinear PCR 
amplification of individual cDNA fragments, the quantification of transcript 
expression through the hybridization analysis of cDNA pools has been 
shown to a reliable indicator of actual mRNA expression levels (Wang and 
Brown, 1991; Ko et al., 1990; C. V. Esguerra, unpublished results). Based 
on this analysis, it was determined that all 24 of these randomly picked 
clones were upregulated in the adult superior colliculus after deafferentation 
(data not shown), and 14 of these 24 clones were also upregulated in the 
embryonic superior colliculus.
Although the verification of the differential expression of these transcripts 
by in situ hybridization and Northern analysis is still in progress, these 
numbers appear to indicate the effectiveness of the rescue hybridization 
procedure in generating cDNA pools that are highly enriched for 
differentially regulated transcripts that satisfy multiple expression-based 
criteria. These results also suggest that the improved subtractive 
hybridization procedure is effective in its enrichment of cDNAs that 
represent transcipts that are actually differentially expressed, which has been 
verified by other applications of this method as well (C. V. Esguerra, 
unpublished results). An additional analysis of the degree of enrichment 
provided by both the improved subtractive hybridization strategy and the 
rescue hybridization procedure is still in progress, yet initial results indicate 
that the final rescue hybridization dramatically increases the frequency of 
those cDNA fragments that are present in both final pools (data not shown). 
This suggests that the positive selection step is quite useful for the rapid 
selection of genes that fulfull multiple expression criteria.
Sequence Analysis of Selected cDNA Clones
The clones that showed increased levels of expression in both embryonic SC 
and deafferented adult SC were analyzed further by sequencing and by 
sequence homology searches in the electronic databases. This sequence 
analysis showed that of the 14 clones, 13 were unique, with 2 clones 
consisting of the same sequence (EN7-12 and EN7-13). In addition, it was 
revealed that of these 13 unique clones, 6  encoded known proteins, 5 
encoded proteins with no significant homology to any known protein, 1 was 
identical to an unknown gene with NGF-induced expression, and 1 clone
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(EN7-10) encoded a novel transmembrane protein with significant 
homiology to EGF-like growth factors (see Figure 6 ).
Further sequence analysis of EN7-10 enabled the identification of the full- 
length sequence of its human homolog based on unpubhshed sequence entries 
in GenBank. This homologous human cDNA displayed approximately 95% 
homology on the amino acid level to the corresponding region encoded by 
EN7-10 (data not shown). Interestingly, this same region from an 
unpublished partial Xenopus laevis cDNA sequence also displayed over 89% 
homology to both rat and human sequences, suggesting a significant 
conservation in the function of this molecule. Additional sequence 
comparisons using the full-length sequence of the human cDNA revealed 
that in addition to its single EGF domain (see Figure 7), it also contains two 
domains with significant similarity to both follistatin and agrin (see Figure 
8 ). This novel structural configuration appears to define a new class of 
EGF-like molecules in addition to the EGF family and the neuregulins (see 
Figure 9). Because of the similarity of EGF domain of EN7-10 to that of 
betacellulin and because of its neuronal expression pattern (data not shown), 
this molecule was named neurocellulin.
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Analysis of Differential Gene Expression by Boolean Selection
Based on these preliminary results, it appears that the Boolean selection 
method is capable of rapidly identifying differentially expressed transcripts 
that satisfy multiple selection criteria. Although additional analysis will be 
necessary to determine the overall efficacy of Boolean selection strategies 
for this and other apphcations, especially with selection schemes that involve 
more than two experimental parameters, it can already be concluded that 
this type of approach may be useful for the process of gene discovery in 
many different biological systems.
Nonetheless, several technical limitations have already become apparent that 
will need to be overcome before this methodology can become universally 
applicable. With single-parameter selections such as {deafferented adult 
superior colliculus NOT normal adult superior colliculus} or (D NOT N}, 
essentially all selected cDNA clones can be shown to be differentially 
expressed according to these criteria, although this will still need to be 
verified with larger numbers of clones. (As mentioned previously, NOT is 
understood to mean "greater than by factor of n '\ where n is at least 2  when 
the ratio of driver cDNA to tracer cDNA is 20.) However, this efficiency is 
significantly decreased by the addition of an additional selection criterion 
such as {deafferented adult superior colliculus AND embryonic superior 
colliculus NOT normal adult superior colliculus} or {D AND E NOT N}. 
In this case the efficiency drops from 100%, where 24 out of 24 clones 
satisfy the criteria {D NOT N ), to only 38%, where 14 out of 24 clones 
satisfy the criteria (D AND E NOT N). This efficiency drops still further 
by the addition of an additional, third selection criterion (data not shown). 
This decrease in selection efficiency necessitates an increase in effort during 
the post-selection analysis steps. Because the actual differential expression 
of the clones must be verified and quantified by blot-based methods that use 
the individual clones as hybridization probes, any significant loss in 
efficiency in the initial selection process increases the redundant effort in 
this latter phase of the screen. The most likely reason for this decrease in
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enrichment fidelity is the use of double-stranded cDNA fragments as driver 
and tracer populations during the subtractive hybridizations, which cause 
trace amounts of common cDNA fragments to remain in the subtracted 
cDNA pools when they should have been removed entirely. This does not 
affect the efficiency of the subtractive hybridization as much as it does that 
of the rescue hybridization, because these trace amounts of common cDNA 
fragments are only enriched to the point of detection during the rescue 
hybridization process. However, an additional effect of the use of double­
stranded cDNA fragments is the need to perform multiple rounds of 
subtraction and reamplification in order to create cDNA pools that are 
suitably enriched for differentially expressed transcripts and that can be used 
for additional rescue hybridizations. These multiple rounds of PCR 
amplification result in an inherent representational bias beeause of the 
dependence of the amplification process on the length of the cDNA 
fragments. Longer fragments are therefore reduced in abundance to the 
point of nondetection.
Another limitation of the methodology as it now stands is the sequence- 
dependent fragmentation and adaptor ligation process, which also inherently 
leads to the misrepresentation of certain transcripts in the original cDNA 
pools. Although most evidence to date points to the fidelity of this process 
in creating representative cDNA populations that reflect the original 
transcript abundance profile of the source tissue (Wang and Brown, 1991; 
Ko et al., 1990; C. V. Esguerra, unpublished results), it is obvious that any 
process that depends on the presence of distinct sequence motifs (in this two 
different four-base restriction sites) w ill result in the inefficient 
amplification of some transcripts because of their length and their lack of 
these sequence motifs. This will also be true for significant portions of 
many other transcripts that do contain these sites, but not at regularly spaced 
intervals.
The solution for both of these problems would be to substantially alter the 
standard cDNA synthesis procedure by using biotinylated oligonucleotide 
adaptors linked to random primers for the first-strand synthesis. By 
carrying out this reaction with an appropriate excess of these random 
primer-adaptors, the length of the resulting single-stranded cDNA fragments 
would be consistantly limited so that all fragments could be amplified with 
approxim ately equal efficiency, given the additional assistance of
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thermostable polymerase mixtures with significantly higher processivities 
(Barnes, 1994). As the generation of amplifiable fragments from all 
transcripts using this approach would be an entirely random, sequence- 
independent process, there would no longer be any significant chance for 
length-dependent bias to occur during the PCR amplification steps. In 
addition, by adding an independent, second primer to the distal end of the 
first-strand cDNA by RNA ligase, thereby allowing the amplification of the 
fragments with two separate primers, it would become possible to generate 
single-stranded fragments of opposite complementarity for the different 
hybridization reactions. For example, by amplifying the driver cDNA 
fragments with one biotin-labeled primer and one digoxygenin-labeled 
primer so that the sense strand is labeled with digoxygenin, it would be 
possible to completely remove the biotinylated antisense strand with 
streptavidinylated beads, thereby generating digoxygenin-labeled, single­
stranded driver cDNA. The same strategy could also be used to generated 
unlabeled, single-stranded tracer cDNA consisting of the complementary 
antisense strand. This would enable both the subtractive hybridizations and 
the rescue hybridizations to be carried out with complementary single­
stranded driver and tracer cDNAs, thereby greatly increasing their 
efficiency and reducing the number of subtractive hybridizations needed for 
the sufficient enrichment of differentially expressed transcripts.
Possible Physiological Relevance of Identified Transcripts
Although additional analysis by in situ hybridization will still be necessary to 
verify the extent of differential expression and to provide information on 
the cellular localization of the transcripts identified so far, it has already 
been possible with this preliminary screen to gain new insight into some of 
the molecular and cellular activities in the superior colliculus during periods 
associated with the formation and reorganization of synaptic connections. 
Some of the identified transcripts encode proteins associated with post- 
transcriptional protein synthesis and m odification events, including 
ribophorin (an essential subunit of the protein glycosylation complex 
oligosaccharyltransferase), calnexin (a membrane-associated molecular 
chaperone of the endoplasmic reticulum), and translation initiation factor, 
which together suggest enhanced levels of protein production and secretion. 
Other transcipts encode proteins that appear to indicate increased neuronal
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activity, such as rSec6  (part of the protein complex involved in the docking 
and fusion of synaptic vesicles to the plasma membrane) and Fyn (a 
nonreceptor tyrosine kinase found at high concentrations in axonal growth 
cones and that is known be involved in synaptic plasticity). Two of the more 
interesting transcripts include Fas-associated protein factor (a recently- 
identified molecule potentially involved in Fas-mediated signal transduction 
during apoptotic cell death), and a novel member of the EGF superfamily of 
transmembrane growth factors (which presently includes the EGF/TGFa 
family and the neuregulins). Further analysis of these molecules may 
provide additional information about the signaling mechanisms and cell-cell 
interactions at work during the establishment and reorganisation of neuronal 
connectivities in the superior colliculus.
Clone 10: Novel EGF-like gene with follistatin-like domains
The EGF family of membrane-anchored growth factors includes epidermal 
growth factor (EGF), transforming growth factor a  (TG Fa), heparin- 
binding EGF-like growth factor (HB-EGF), amphiregulin, betacellulin, and 
teratocarcinoma-derived growth factor (TDGF, also known as cripto). 
These proteins all contain one EGF domain and with the exception of TDGF 
are known to be ligands for the EGF (erbB) receptor (EGFR). The 
neuregulins, an additional family of EGF-like proteins that encompasses 
numerous splice variants of a single transcript, alternatively called glial 
growth factors (GGFs), heregulins, neu differentiation factor (NDF) and 
acetylcholine receptor inducing activity (ARIA), are characterized by an 
immunoglobulin domain in addition to the single EGF domain and are 
known to interact with the EGFR-like receptors erbB2 (neu), erbB3, and 
erbB4 (Carraway and Burden, 1995). The protein encoded by clone 10 
appears to define an additional, third class of EGF-like molecules that is 
characterized by two follistatin domains in place of the immunoglobulin 
domain present in the neuregulins. Because of the predomininant expression 
of this transcript within the central and peripheral nervous systems (data not 
shown) and the similarity of its EGF domain to that of betacellulin, the 
protein it encodes was named neurocellulin.
It is not yet clear whether the EGF domain of neuroeellulin is eapable of 
binding the EGF receptor or any of the three EGFR-like receptors. Both
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neurocellulin and TDGF differ slightly from the consensus sequence of the 
remaining EGF superfamily members (including the neuregulins), which is 
CX7CX2GX1.2CX 10-13CXCX3Y/FX1GX1RC. This structure, which folds into 
an open hairpin-loop configuration with three disulfide bonds, contains an 
arginine immediately proximal to the final cysteine that has been shown to 
be necessary for EGF receptor binding and activation by TG Fa (Defeo- 
Jones et al., 1989). This arginine is likely to be similarly important for the 
interactions of other superfamily members with their respective receptors 
and is substituted by histidine in neurocellulin, raising the question of 
whether neurocellulin interacts with other, still unknown EGFR-like 
receptors. In the EGF domain of TDGF this single arginine is substituted by 
asparagine, yet TDGF was shown to possess mitogenic activity, indicating 
that these conservative substitutions either do not interfere with binding to 
the known members of the EGF receptor family, or that they specify 
interactions with other receptors.
Growth factors of the EGF superfamily have widely divergent actions on 
numerous cell types. TG Fa was originally found in the culture medium of 
various retrovirus-transformed fibroblasts and was identified by its ability 
to stimulate the proliferation of normal fibroblasts (DeLarco and Todaro, 
1978), an effect later shown also to be dependent on the action of TGFP 
(Anzano et al., 1983; Massague, 1983). Since then it has been found to be 
expressed in numerous tissues, including various regions of the nervous 
system (Kaser et al., 1992; Wilcox and Derynck, 1988), where it was 
recently shown to stimulate the survival and neurite outgrowth of 
mesancephalic dopaminergic neurons (Alexi and Hefti, 1993). EGF is also 
widely expressed throughout the nervous system (Birecree et al., 1991) as is 
the EGF receptor (Seroogy et al., 1995; Birecree et al., 1991) which has 
also been found to be upregulated in Schwann cells after lesions in the sciatic 
nerve (Toma et al., 1992), suggesting its potential role in mediating events 
related to neuronal regeneration.
As the prototype molecule of the EGF/TGFa class of transmembrane growth 
factors, T G Fa and the molecular mechanisms of its actions have been 
studied in considerable detail. Although initially assumed to be active only 
in soluble form after release from the cell membrane by proteolytic 
cleavage (Pandiella et al., 1991), it was demonstrated that TG Fa is also able 
to stimulate the growth of neighboring cells while still anchored to the ceU
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membrane (Wong et al., 1989; Brachmann et al., 1989). This mode of 
action has been termed "juxtacrine" activity. Another intruiguing finding 
was that TG Fa may itself act to transduce signals from the cell surface to 
the cytoplasm in a fashion similar to that of classical transmembrane 
receptors (Shum et al., 1994). This is suggested by the association of the 
transmembrane form of TG Fa with a protein kinase complex, raising the 
possibility that an interaction between TG Fa and the EGF/TGFa receptor 
leads to reciprocal signaling events. Given the high degree of homology 
(over 98% on the amino acid level) within the transmembrane and 
cytoplasmic domains of neurocelluhn between its mammalian and amphibian 
homologs, it is possible that this part of the protein is involved in similar 
protein-protein interactions during the initation of specific signal 
transduction events. An additional or perhaps alternative explanation for 
this significant conservation of sequence homology may be that neurocellulin 
is targeted to distinct locations within the plasma membrane by virtue of the 
interactions of these regions with components of the cytoskeleton or other 
membrane-associated proteins.
In addition to the single EGF domain adjacent to the transmembrane region, 
neurocellulin contains two follistatin-like regions in the N-terminal part of 
the protein. These follistatin-like domains might be also be indirectly 
involved in activating growth factor receptors. It has been speculated that 
the follistatin-like regions of agrin and agrin-related proteins serve to bind 
and localize molecules of the transforming growth factor (3 and platelet- 
derived growth factor families, thereby creating localized matrix-associated 
concentrations of them (Patthy and Nikolics, 1993). There are numerous 
lines of evidence to support this hypothesis. First, it is well known that 
follistatin binds activin with high affinity (Nakamura et al., 1990), thereby 
blocking its action on gonadotrophs and inhibiting the release of follicle- 
stimulating hormone (FSH). Follistatin is also known to bind inhibin, 
another member of the TGFp superfamily that shares one of two subunits 
with activin (Shimonaka et al., 1991). Furthermore, osteonectin/SPARC, 
another protein containing the follistatin module, has been shown to bind the 
platelet-derived growth factors (PDGF) AB and BB, thereby preventing 
these from binding the PDGF receptor (Lane et al., 1991; Raines et al., 
1992). This raises the possibility that the follistatin-like regions in 
neurocellulin, agrin, and SCI, an osteonectin-related glycoprotein found in 
brain extracellular matrix (Johnston et al., 1990), are capable of binding
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members of the PDGF family as well. Given the known roles of agrin and 
SCI in synapse formation (Gautam et al., 1996; Johnston et al., 1990) and 
the neuronal expression of PDGF (Yeh et al., 1990; Sasahara et al., 1990), it 
may be the case that the modulation of PDGF activity by agrin or SCI is 
important for the process of synaptogenesis.
It remains to be seen which growth factors are bound by neurocellulin and 
how these signaling activities are modulated by the interaction with 
neurocellulin. Enhanced expression of members of the transforming growth 
factor P superfamily has been documented following lesions and/or the loss 
of synaptic input (Nichols et al., 1991; Finch et al., 1993). It has been 
suggested that the increase in TGFP expression may serve in part to induce 
the resynthesis of extracellular matrix that is lost as the result of 
degeneration of afferent fibers (Pasinetti et al., 1993). Some results point to 
the role of TGFp-like molecules in inducing apoptotic cell death (de Luca et 
al., 1996), whereas in other experimental contexts it appears that these 
factors are able to promote survival of neurons (Schubert et al., 1990; 
Krieglstein et al, 1995) and to protect them against excitatory amino acid- 
mediated neurotoxicity by stabilizing calcium ion homeostasis and inducing 
expression of the Blc2 oncoprotein, an inhibitor of apoptotic cell death 
(Prehn et al., 1994). Clearly the scope of actions of these diverse molecules 
depends on the cellular context in which their action takes place, so it cannot 
be predicted what growth factor-mediated effects neurocellulin is able to 
modulate.
Additional intriguing results that point to the potential interaction between 
neurocellulin and TGFp-like molecules include the potent inhibition by 
TGFp of hepatocyte growth factor (HGF) secretion in fibroblasts (Gohda et 
al., 1992) and recent in situ hybridization data that indicate partially 
overlapping expression patterns of neurocellulin with HGF throughout the 
rat brain (S. Isenmann, personal communication). One possible explanation 
for these findings could be that the follistatin domains in neurocellulin act in 
an inhibitory fashion to block the action of TGFP and similar molecules, 
thereby enabling HGF secretion to take place. It should be noted, however, 
that the observed interaction between HGF and TGFP was seen with human 
fibroblasts and that similar results cannot be assumed for the various 
neurons that express neurocellulin and HGF. Further analysis will be 
necessary to correlate the neuronal expression patterns of the various
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members of the TGPP superfamily with the expression of neurocellulin and 
HGF. Any functional interactions that may occur between these different 
classes of molecules will then have to be determined in an in vitro 
environment.
As mentioned previously, it will be necessary to determine the binding 
affinities of the two follistatin domains of neurocellulin for all TGFPs, 
growth/differentiation factors (GDFs), bone morphogenic proteins (BMPs), 
activins and inhibins, and glial cell line-derived neurotrophic factor 
(GDNF), as well as for the PDGFs and the neurotrophins. It is quite 
possible that the two follistatin domains of neurocellulin bind several of 
these different growth factors with widely divergent affinities, thereby 
giving rise to quite different forms of molecular interaction, such as 
complete inactivation in the case of higher affinities and limited binding and 
release (or presentation to receptors) in the case of lower affinities. The 
proximity of the two follistatin-like regions in neurocellulin suggests that 
they may indeed be involved in the presentation of these growth factors to 
their receptors, given the need for most cell surface receptors to dimerize in 
order for the signal transduction process to be initiated (Heldin, 1995). In 
the case of receptors with either serine/theonine or tyrosine kinase activity, 
the proximity or local concentration of ligands is a critical factor in 
determining whether receptor dimerization occurs. Factors that bind these 
ligands and thereby create localized matrix-bound concentrations of them, 
such as heparan sulphate proteoglycans in the case of TGFPs or fibroblast 
growth factor (Lopez-Casillas et al., 1993; Spivak-Kroizman et al., 1994; 
Ruoslahti and Yamaguchi, 1991), serve in part to promote receptor 
dimerization and the subsequent initiation of signal transduction. It remains 
to be seen whether the two follistatin-like regions in neurocellulin are 
capable of simultaneously binding different growth factors, leading to the 
heterodimerization of the corresponding receptors and perhaps to the 
initiation of specific signal transduction pathways.
Another interesting aspect of follistatin-like protein domains is their own 
ability to bind to heparan sulphate proteoglycans (Nakamura et al., 1991). 
This property may enable the indirect attachment of follistatin-bound 
growth factors to components within the extracellular matrix, thereby 
providing receptors on neighboring cells with localized reservoirs of 
ligands. It has been shown that the binding of follistatin to heparan sulphate
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does not interfere with those molecular interactions that are necessary for 
binding growth factors, despite the fact that these different interactions are 
mediated by the same protein region (Sugino et al., 1993; Inouye et al., 
1992). It is not unlikely that high-affinity associations of the two foUistatin- 
like regions in neurocellulin with glycosaminoglycans allow for the 
localization of the EGF domain of neurocellulin to the extracellular matrix, 
enabling its accumulation within extracellular spaces in the vicinity of 
neurocellulin-expressing neurons. An intruiging possibility is that 
neighboring neurons and glia secrete specific proteases that cleave the EGF 
domain from matrix-bound neurocellulin, thereby allowing the activation of 
its receptor on these cells. Similar mechanisms have been shown to be 
involved in the release of ARIA, one of several neuregulin variants 
responsible for the induction of acetylcholine receptor expression in 
postsynaptic neurons, from the extracellular matrix (Loeb and Fischbach, 
1995). It has previously been demonstrated that the EGF-like domain of 
neuregulin is sufficient for receptor binding and activation (Holmes et al., 
1992; Wen et al., 1994), leaving open the possibility that this is the case for 
neurocelluhn as well.
Aside from the potential molecular mechanisms of action of neurocellulin, 
there remains the question of the scope and nature of this action. Expression 
of neurocellulin has been observed in embryonic retinal ganglion cells 
throughout the phase of axonal outgrowth and is undetectable in adult retinal 
ganghon cells (S. Isenmann, personal communication), but is again observed 
during the axonal regeneration of adult retinal ganglion cells into peripheral 
nerve grafts after transection of the optic nerve (C. V. Esguerra, personal 
communication). It may be the case that neurocellulin either acts in an 
autocrine fashion to promote neurite outgrowth or that it acts in the same 
fashion as glial growth factor, one of several neuregulin variants, in 
promoting the survival of glial cells or perhaps even of target neurons and 
in stimulating their secretion of factors needed for trophic support and 
neurite outgrowth (Mahanthappa et al., 1996; Trachtenberg et al., 1996). 
Functional studies, such as co-culture experiments with transfected cell lines 
and primary neurons and/or glia, will be needed to address these questions 
in more detail. An additional approach to determine the in vitro effects of 
neurocellulin on various cell types could be done at the molecular level, 
through the identification of neurocellulin-incuced transcripts.
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Clone 22: Fas-associated protein factor, FA F l
Fas, a member of the tumor necrosis factor (TNF) receptor family, is 
known to trigger cell death by apoptosis when activated by Fas ligand (FasL) 
binding or by anti-Fas antibody crosslinking (Nagata, 1994). Fas-mediated 
apoptotic cell death has been shown to have an important function in the 
development and function of the immune system (Nagata, 1994; Lowin et 
al., 1994), but the molecular mechanisms by which Fas transduces apoptotic 
signals from the cell surface to the cytoplasm are not yet well understood. 
Fas-associated protein factor was recently identified by a yeast two-hybrid 
screen for proteins that specifically interact with the wild-type cytoplasmic 
domain of Fas, but not with the altered form of Fas found in Ipr^s 
(lymphoproliferation) mutant mice (Chu et al., 1995). The mutation 
results in a single base change within the death domain, replacing isoleucine 
with asparagine and thereby completely abolishing the signal-transducing 
properties of Fas (Watanabe-Fukunaga et al., 1992). This and other 
naturally occuring mouse mutants such as Ipr and gld (g en e ra lized  
lymphoproliferation disease), all characterized by the loss or inactivation of 
Fas or FasL, develop lymphadenopathy and systemic lupus erythematosus- 
like autoimmune disease, implicating Fas-mediated apoptosis in the deletion 
of autoreactive lymphocytes. Gene targeting studies have also shown the Fas 
pathway to be involved in the elimination of tumor cells and virus-infected 
cells mediated by cytotoxic T lymphocytes and natural killer cells (Lowin et 
al., 1994).
Subsequent functional analysis of Fas-associated protein factor by transient 
overexpression in Fas-expressing COS cells revealed that FAFl potentiates 
Fas-mediated cell death induced by antibody-crosslinking (Chu et al., 1995). 
This result, in combination with the verification that FAFl specifically 
interacts with the wild-type death domain of Fas but not witli tlie mutant 
form deficient in signal transduction, suggests that FAFl is part of the Fas 
signal transduction pathway and that it acts downstream of Fas in the 
induction of apoptosis. It is not yet clear, however, whether this interaction 
is ligand dependent, i.e. whether FAFl preferentially binds dimeric as 
opposed to monomeric Fas. Other proteins recently shown to specifically 
associate with the wild-type cytoplasm ic domain of Fas include 
FADD/MORTl and RIP, yet these contain death domains homologous to that 
of Fas and are capable of inducing apoptotic cell death on their own, which
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is not the case for FAFl (Chinnaiyan et al., 1995; Boldin et al., 1995; 
Stanger et al., 1995). It remains to be seen whether FAFl functions 
downstream of multiple death domain-containing proteins during apoptotic 
signal transduction or whether it associates exclusively with Fas.
Another interesting question is whether FAFl is also involved in non- 
apoptotic signal transduction mediated by Fas or other death domain- 
containing receptors. In addition to Fas, the TNF receptor family includes 
the TNF receptors (P55 and P75), CD40, 0X40, CD27, CD30, 4 -IBB, and 
the low affinity NGF receptor. These receptors are capable of mediating 
very divergent cellular reponses, including not only apoptosis but also cell 
proliferation and differentiation (Baker and Reddy, 1996; Smith et al.,
1994). Fas has also been shown to mediate cell proliferation in certain cell 
types (Owen-Schaub et al., 1993; Alderson et al., 1993), yet the signal 
transduction pathway for such non-apoptotic responses is poorly understood 
as well, leaving open the possibility of any involvement of FAFl in these 
processes. An intriguing connection between the molecular mechanisms 
involved in apoptosis and those involved in axonal guidance was recently 
made with the observation that the death domain motif is also present in 
proteins such as unc-5 and unc-44, an ankyrin-related protein (Hofmann and 
Tschopp, 1995). Both proteins are necessary for the guidance of pioneer 
axons and migrating cells in Caenorhahditis elegans, raising the possibility 
that the death domain mediates protein-protein interactions involved in 
cytoskeletal rearrangement, which is also an early event of apoptosis.
The role of receptor-mediated apoptosis in the development and function of 
the nervous system has not yet been specifically examined (Rabizadeh and 
Bredesen, 1994). Nonetheless, cell death has long been recognized as an 
im portant phenomenon during neuronal differentiation and in the 
establishment of neuronal connectivities (Rubin et al., 1994; Gould and 
McEwen, 1993). Although most work on neuronal death has focused on the 
interactions between neurons and their targets, there are now several lines of 
evidence underscoring the importance of afferent inputs in regulating 
neuronal survival as well, both during development and in the mature 
nervous system. For example, in the ciliary ganglion (CG) of the chick 
embryo, which is made up of peripheral autonomic neurons that project to 
the eye musculature and that receive afferent inputs exclusively from the 
accessory oculomotor nucleus (AON), as many additional neurons die after
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the removal of the input, the AON, as do after the removal of the target, the 
optic vesicle (Furber et al., 1987). Whereas usually 50% of CG neurons die 
by the end of the normal cell death period (E l4 to E l5), the early (E4) 
surgical removal of either AON or optic vesicle results in the degeneration 
and death of up to 90% of CG neurons. The cell death resulting from the 
loss of preganglionic input is not due to the failure to CG neurons to 
innervate their target, as this was shown to still occur. Moreover, the 
combined loss of both input and target results in the death of virtually all 
remaining neurons, indicating the ability of the afferent inputs to sustain the 
survival of those CG neurons deprived only of their targets. Comparable 
results have been obtained for the parabigeminal nucleus of the rat (Linden 
and Renteria, 1988; Linden and Pinon, 1987), indicating the role of afferent 
supply in determining the survival of neurons.
In summary, the observed increases in FA Fl expression may be an 
indication of the occurance of apoptotic cell death, mediated by Fas or other 
death domain-containing receptors, in the superior colliculus during 
embryonic development as weU as after the loss of afferent input. It might 
be possible that this increased expression of FAFl and perhaps also of other 
components of the cell death pathway occurs during periods of synapse 
formation in order to prime postsynaptic neurons for apoptosis, should the 
required synaptic connections not be established. Additional investigations of 
cell death in the superior colliculus are warranted, especially an analysis for 
the presence of apoptosis-associated markers, including DNA fragmentation 
as visualized by TUNEL and the expression of FasL and other functionally 
related molecules such as tumor necrosis factors.
Clone 4: Fyn tyrosine kinase
Fyn is one of several well-characterized nonreceptor tyrosine kinases 
(including also Src, Yes, and Abl) that participate in numerous signal 
transduction pathways in neurons and other cell types. It was originally 
identified on the basis of its sequence homology to Src (Kawakami et al., 
1988) and has subsequently been shown to be developmentally regulated in 
different neuronal cell types (Ingraham et al., 1992; Maness, 1992) as well 
as in various cells of the haematopoietic lineage (Toyoshima et al., 1992). 
Its primary function appears to be the mediation of signal transduction
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events that are initiated by the activation of cell-surface receptors, including 
the EGF receptor (Margolis et al., 1992), the receptor for macrophage 
colony-stimulating factor (Courtneidge et al., 1993) and Sek, of the Eph 
receptor family (Ellis et al., 1996). Its interaction with the PDGF receptor 
(Twamley et al., 1992) suggests that Fyn might be involved in the regulation 
of oligodendrocyte proliferation. Recent analysis of Fyn expression has 
shown it to be abundant in neuronal growth cones, implicating it in the 
regulation of neurite outgrowth and perhaps axon guidance (Bixby and 
Jhabvala, 1993).
There are several lines of evidence which suggest that Fyn is also involved 
the regulation of synaptic plasticity. First, the protein was found to be one 
of the major components of the post-synaptic density (PSD) fraction 
prepared from mouse forebrain, and was implicated in the tyrosine 
phosphorylation of two other proteins in this fraction, the epsilon subunits 
of the NMD A receptor (Suzuki et al., 1995). Second, the analysis of mice 
homozygous for the targeted deletion of the fyn  gene demonstrated that Fyn 
appears to be required for the NMDA-receptor mediated induction of long­
term potentiation, an important form of activity-dependent synaptic 
plasticity (Grant et al., 1992). Mutant mice display an impairment in spatial 
learning, as well several behavioral deficits including the disturbance of 
instinctive suckling behaviour in newborns (Yagi et al., 1993).
In addition, there have been several recent results which indicate that Fyn 
m ight be involved  in signal transduction  through glycosyl- 
phosphatidylinositol-anchored cell-surface proteins. In the immune system, 
it could be demonstrated that the induction of lymphocyte proliferation 
through the activation of the membrane-associated decay-accelerating factor 
(DAF, also known as CD55) is dependent upon the interaction of Fyn with 
its GPI anchor (Shenoy-Scaria et al., 1992). In the nervous system, the 
immunoglobulin superfamily member F3, a plurifunctional GPI-anchored 
molecule predominantly expressed on axons and a known modulator of 
neurite outgrowth, was found to associate with both Fyn and L I, another 
GPI-anchored cell adhesion molecule, suggesting that this complex may be 
involved in the mediation of F3 signaling events (Olive et al., 1995). Fyn 
was also found to interact with the GPI-linked neuronal cell adhesion 
molecule contactin/Fl 1 (Zisch ct al., 1995), indicating that the signaling 
pathway through which GPI-anchored cell-surface molecules respond to
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external stimuli such as receptor binding involves Fyn and possible other 
member of the Src family of nonreceptor tyrosine kinases.
Given the ability for GPI-linked proteins to be transferred between cells 
(Ilangumaran et al., 1996), this indicates the possibility of a novel form of 
intercellular communication involving the transfer of GPI-anchored signal- 
transducing molecules to cells that may not actually express these proteins. 
This acquisition of signal transduction capacity is qualitatively different 
from other forms of ligand-induced signaling because its potential for more 
rapidly initiated, relatively stable, and highly localized alterations in cellular 
phenotype. One possible example of this might be the numerous interactions 
between axonal growth cones and other neurons or their processes, which 
could involve the transfer of GPI-anchored molecules in either direction, 
giving the growth cone (or its counterpart) an additional mechanism by 
which to acquire and process positional information. Considering the high 
concentrations of Fyn in embryonic growth cones, it would not be 
surprising if, in addition to its modulation of receptor-mediated signal 
transduction, this tyrosine kinase is responsible for signaling events mediated 
by GPI-linked proteins transferred from other cells.
In summary, it is difficult to determine what cellular events and functions 
might be indicated by the observed increases in Fyn expression in the 
superior colliculus during during phases of synapse formation and 
reorganization. One of the more likely explanations could be the increased 
degrees of axonal outgrowth in the embryo and of axonal sprouting in the 
lesioned adult, yet this would still have to be determined by an 
immunohistochemical analysis of Fyn protein expression.
Clone 2: rSec6
Several proteins involved in the life cycle of the synaptic vesicle have been 
identified as homologues of yeast proteins responsible for vesicle trafficking 
between Golgi bodies and the plasma membrane. rSec6  was recently 
identified by homology cloning as the mammalian equivalent of Sec6 p (Ting 
et al., 1995), one of several components of the soluble 19.5S complex in 
yeast that interacts with the vesicle-associated GTP-binding protein Sec4p 
(Potenza et al., 1992). There is increasing evidence that this particle is
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involved in the formation of the 7S complex (consisting of VAMP, 
synaptotagmin, syntaxin, and SNAP-25) and the 20S complex (consisting of 
VAMP, syntaxin, SNAP-25, a-SNAP, and NSF) which were recently 
identified as putative synaptic vesicle docking/fusion particles in the 
presynaptic terminal (Sollner et al., 1993a, 1993b).
From genetic studies with the yeast homologs of these proteins, it has 
become apparent that rSec6  and rSec8 may associate with Rab3a, the 
manunalian homolog of Sec4p, to mediate the delivery and docking of the 
synaptic vesicle to the plasma membrane (Aalto et al., 1993; Brennwald and 
Novick, 1993). The IS  complex is formed during the docking step by the 
association of the two vesicle-associated proteins VAMP and synaptotagmin 
with the plasma membrane-associated proteins syntaxin and SNAP-25. 
N euro transmitter release caused by the calcium-induced fusion of synaptic 
vesicles with the plasma membrane is preceded by the formation and 
dissociation of the 20S complex. Although the exact molecular functions of 
rSec6  within this cascade of events are only beginning to be elucidated, it is 
clear that this factor plays an important role in synaptic vesicle-mediated 
neurotransmitter release.
Enhanced expression of proteins such as rSec6  that are involved in the life 
cycle of the synaptic vesicle may therefore be an indicator of increased 
neurotransmitter release, both in neurons of the embryonic colliculus as well 
as of the adult colliculus after the loss of afferent inputs. This increase in 
synaptic activity may well be associated with the target-associated synaptic 
plasticity and reorganization that is known to occur in the embryonic brain 
during the phase of innervation and in the adult brain as the result of 
deafferentation. The loss of afferent input to the superior colliculus has 
been shown to result in the elimination of most affected synapses, 
subsequently leading to significant synaptic reorganization and reinnervation 
that may enable some deafferented neurons to be resupplied with alternate 
synaptic inputs (Lund and Lund, 1971a, 1971b). This reafferentation might 
prevent these neurons from undergoing cell death, which usually results 
from the loss of afferent inputs (Furber et al., 1987). Further studies will 
need to be untertaken in order to examine more closely these potential 
relationships between neurotransmission, synaptic reorganization, and cell 
death in the superior colliculus during development and following 
deafferentation. One possible approach would be examine the effects of a
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chemically-induced blockage of synaptic transmission on synapse formation 
through electrophysiological recording and dye-labelling, and to combine 
this with an analysis for markers of programmed cell death.
It should be mentioned that an alternative explanation for the increase in 
neurotransmitter release after deafferentation might also simply be the 
spurious activity of existing neuronal circuits after the loss of their afferent 
inputs, or of the additional activity of aberrant connections formed as the 
result of the synaptic reorganization and reinnervation mentioned above. 
There has been much speculation as to the potential causes of deafferentation 
pain in human patients (Davar and Maciewicz, 1989; Sweet, 1988), and at 
least one possible contributing factor to this phenomenon might be the 
formation and spurious activity of such abberant synapses that lead to the 
disfimctional activity of various sensory neurons.
Clone 21: NGF-induced EST
Recently, an expressed sequence tag analysis of differential gene expression 
in PC-12 cells was carried out for the identification of transcripts whose 
expression was affected by treatment with nerve growth factor (Lee et al.,
1995). The rat pheochromocytoma cell line PC-12 acquires neuron-like 
characteristics when grown in the presence of NGF, including the 
elaboration of neurite-like processes, an arrest of cell division, and the 
acquisition of electrical excitabihty (Greene and Tischler, 1982; Halegoua et 
al., 1991), and can therefore be considered an appropriate model system for 
the analysis of certain aspects of neuronal differentiation. By obtaining 
expressed sequence tags of over 6,000 randomly picked clones from 
primary cDNA libraries of both untreated and NGF-treated PC-12 cells, it 
was possible to generate expression profiles of these cells that could be 
com pared to determine the changes induced by NGF. Over 600 
differentially regulated transcripts were identified by this approach, 
including many transcripts encoding proteins involved in cellular pathways 
not known to be regulated by NGF, as well as numerous transcripts that 
exhibited no significant sequence homologies to known genes. Clone 21 is 
identical to one of these novel ESTs, raising the possibility that this 
transcript is one that is associated with neuronal growth and differentiation.
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Clone 23: Ribophorin
Ribophorin was originally identified as an abundant integral membrane 
glycoprotein restricted to the rough endoplasmic reticulum (Kreibich et al., 
1978) and is thought to be one of several components regulating the 
cotranslational translocation of nascent polypeptides into the RER lumen (Yu 
et al., 1990). Recent evidence also indicates that ribophorin is also part the 
oligosaccharyltransferase complex, an abundant N-linked glycosylation 
activity that is also associated with the RER and which is responsible for the 
transfer for the transfer of high mannose oligosaccharides to asparagine 
acceptor sites within these nascent, unfolded polypeptides during the 
translocation process (Kelleher et al., 1992). Enhanced expression levels of 
this protein in the superior colliculus during development and following 
deafferentation indicate increased levels in the synthesis of membrane- 
associated and secreted N-linked glycoproteins.
Clone 7: Calnexin
Calnexin is also an integral membrane protein of the endoplasmic reticulum 
and has been shown to associate with numerous nascent membrane and 
secretory proteins via their carbohydrate moieties (Bergeron et al., 1994). 
This interaction takes place during the translocation process and constitutes 
activities previously thought to be restricted to soluble chaperones of the 
heat shock protein families. In addition to its ability to capture unfolded 
glycoproteins through its lectin-like affinity for early intermediates in the 
processing of N -linked oligosaccharides, calnexin has also been 
demonstrated to bind misfolded and incompletely folded proteins, indicating 
that it may function as part of the quality control apparatus that prevents 
proteins from continuing along the secretory pathway unless they have 
acquired the proper structural conformation. Upregulation of calnexin may 
therefore also indicate higher rates of synthesis of secretory and membrane- 
bound glycoproteins. These proteins may include molecules involved in 
mediating cell-cell interactions during the establishment of neuronal 
connectivities in the superior colliculus, such as trophic factors and their 
corresponding receptors, extracellular matrix proteins, and cell adhesion 
molecules. Further analysis of the cDNA clones in the EN? library may
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provide additional clues as to which additional molecular interactions are 
associated with this process.
Clone 12: Translation initiation factor
Although this and most other studies on the regulation of gene expression 
have focused on transcriptional control, there are clearly additional 
mechanisms that allow cells to regulate the synthesis and activity of proteins. 
One of these mechanisms is the regulation of translation initiation (in 
addition to the control of mRNA conformation and stability, as well as the 
regulation of protein folding, post-translational modification, and secretion). 
One of the major criticisms of transcript-based methods for the analysis of 
differential gene expression has been that changes at these other levels of 
control cannot be monitored by examining changes at the mRNA level. 
Nevertheless, at the very least it may be possible to determine whether non- 
transcriptional mechanisms ^ e  involved in certain cellular responses by 
examining the expression of transcripts that encode essential components of 
these other control systems. Translation initiation factors are involved in 
the regulation of eukaryotic translation initiation (Lindahl and Hinnebusch, 
1992) and are themselves subject to various levels of control, including 
phosphorylation by signal transduction pathways activated by extracellular 
factors (Frederickson and Sonenberg, 1992) as well as the post-translational 
conversion of specific amino acids (Park et al., 1993). Because initiation is 
the rate-limiting step in protein translation, the regulation in the rate of 
initiation is an essential factor in determining the overall level of cellular 
activity. Increased levels in expression of an initiation factor, therefore, 
correlate well with the observed changes in ribophorin and calnexin 
transcription and suggest an elevated degree of protein synthesis and cellular 
activity in the superior colliculus during the formation and reorganization of 
synaptic connections.
An Approach for the Systematic Analysis of Gene Expression
In addition to the possible physiological significance of the transcripts that 
have been identified in this initial screen, several conclusions can already be 
drawn as to the use of this type of strategy for the analysis of differential
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gene expression. There several inherent limitations to this type of approach, 
including above all the number of experimental parameters that can be 
analyzed and the amount of gene expression data that can be generated for 
any given system. Because of the need to analyze the expression of the 
different transcripts on an individual basis after the initial selection process, 
the sampling depth becomes limited to such an extent that saturation cannot 
be reached in any individual screen, thereby strictly limiting the amount of 
new expression information that is generated. Therefore, although Boolean 
selection may represent an improvement in terms of differential cloning as 
far as the identification of individual transcripts is concerned, it is not an 
answer to the need for an approach that is capable of quantitatively 
analyzing the expression of many transcripts in parallel.
This type of systematic analysis is, however, the only possibility for 
reaching an understanding of the entire spectrum of molecular mechanisms 
that are the basis of all cellular activities. If individual cells are regarded as 
a complex, dynamic integrators of multiple input signals - regardless of the 
physical nature of these signals - then it is clear that many cellular 
components can either directly or indirectly influence cellular responses to 
these inputs. It would therefore be of considerable interest to be able to 
quantitatively analyze the complete genetic activity of individual cells in 
order to determine their overall biochemical composition, and to be able to 
compare this data from many different cells. It is only in this manner that 
the analysis of differential gene expression would be able to significantly 
contribute to an understanding of cellular phenomena.
Traditional methods for the analysis of gene expression are, however, not 
suitable for this type of approach. All involve the use of simple probes 
representing single genes in order to determine the presence of these probes 
in complex targets using procedures that are relatively labor-intensive (such 
as quantitative RT PCR, Northern blot hybridizations, RNase protection 
assays, and in situ hybridizations). Although whole-mount in situ 
hybridizations are being optimized for high-throughput approaches in both 
zebrafish and mouse embryos (W. Driever and B. Hermann, personal 
communication), this is not an option for the comprehensive analysis of gene 
expression for the simple reason that the number of possible experimental 
parameters vastly outweighs the estimated number of genes in the average 
vertebrate genome. For example, each new experimental parameter not
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included in the original collection of in situ hybridization targets (new 
mutations, transgenes, pharmacological agents, combinations thereof, as well 
as different developmental or experimental timepoints) would necessitate 
tens of thousands of additional in situ hybridizations with the same probes 
used in the original analysis. Additional limitations of whole-mount in situ 
hybridization include the lack of cellular resolution, quantitive capacity, and 
access to later developmental stages (including adult), which could of course 
be offered by the analysis of tissue sections, yet only at the cost of significant 
decreases in efficiency.
Similar arguments apply to approaches involving the generation of large 
numbers of expressed sequence tags for the quantification and comparison of 
gene expression (Adains et al., 1995; Okubo et al., 1992). In addition to 
being prohibitively expensive, EST analysis is limited to comparisons of 
very few samples and only of relatively abundant transcripts within these 
samples. Other technologies for the identification of differentially expressed 
genes, such as the Boolean selection scheme described here, as well as 
classical subtractive cloning approaches, differential display, and related 
methods, are also limited to the examination of very few samples, while 
novel genes must be characterized further individually. One final 
disadvantage common to EST analysis, most differential cloning methods, 
and blot-based RNA quantitation is that the requirement for relatively large 
amounts of source material severely restricts the cellular resolution of the 
expression data that is obtained.
An alternative approach would be the high-throughput, high-resolution, and 
comprehensive analysis of gene expression by combining aspects of the 
recently developed reference library system (Zehetner and Lehrach, 1994; 
Gress et al., 1994; Lennon et al., 1996) with the saturation offered by 
normalized cDNA libraries and the cellular resolution offered by the 
generation of cDNA probes from single cells. This would involve the 
generation of one master reference library that contains cDNA clones of 
most expressed genes of an organism, the robotic arraying of this library 
and production of multiple copies of high-density gridded library filters, 
and the hybridization analysis of these filters with complex cDNA probes 
(Zhao et al., 1995; Auffray et al., 1995; Harrison et al., 1995; Gress et al., 
1992) generated from large numbers of tissue-specific and cell-specific 
mRNA samples. This system would have the advantage of being able to
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easily produce and distribute these library filters to laboratories worldwide, 
allowing for the subsequent coordinated integration of additional 
experimental data with the gene expression information.
In addition to the technical and logistical advances offered by the reference 
library system, there are two other recent developments that would enable 
this type of analysis. The first is an approach for the generation of cDNA 
libraries that contain all clones at approximately equal levels of abundance 
(Soares et al., 1994; Sasaki et al., 1994; Takahashi and Ko, 1994; Patanjali et 
al., 1991; Ko, 1990). The composition of standard cDNA libraries reflects 
the profile of gene expression of the tissue from which they are made, 
creating the problem that abundantly expressed genes make up the majority 
of the clones for any given library. Normalized cDNA libraries, however, 
have reduced levels of these abundant clones and therefore enable the 
detection of more weakly expressed genes that might otherwise not be 
included in finite collections of clones. Similar to most subtraction 
procedures, normalization involves the renaturation of tracer mRNA or 
cDNA with driver cDNA and the subsequent removal of driver-tracer 
duplexes, with the difference that driver and tracer samples are identical. 
The rate of duplex formation is according to second-order reaction kinetics 
and is therefore dependent upon the abundance of individual mRNAs or 
cDNAs, which in this case is identical between driver and tracer pools. This 
principle allows for the specific removal of mRNA or cDNA species at a 
rate that is proportional to their original abundance, thereby creating pools 
with approximately equal abundance levels of all clones.
The second recent development that would enable this type of approach is 
the reliable PCR amplification of mRNA from single cells (Brady et al., 
1995, Karrer et al., 1995; C. V. Esguerra, unpublished results). By 
modifying these methods with the introduction of solid-phase techniques for 
the manipulation of mRNA and cDNA, this technology would enable the 
generation of high-quality single-stranded hybridization probes from single 
cells, which could then be used to probe high-density cDNA library filters to 
quantitatively determine the comprehensive expression profile of these cells. 
Such procedures could of course also be adapted to analyze other small 
samples, such as groups of cells removed from cryostat sections (Luqmani 
and Lymboura, 1994) or other microdissectcd tissues. The deteetion of 
weakly expressed transcripts within these individual cells could be achieved
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through the controlled normalization of the cDNA probes to specific Cot 
values.
In summary, the systematic analysis of cell-specific gene expression, carried 
out through the hybridization of high-density filter arrays of normalized 
cDNA libraries with cell-specific and tissue-specific probes, would allow for 
the rapid generation of high-resolution expression data for the majority of 
genes in an organism. The recent development of glass microarrays (Shena 
et al., 1995) in place of polymer filters might allow for an even greater 
thoughput and sensitivity for this process. Once sufficient numbers of 
probes have been analyzed, this expression data could be used to correlate 
the activity of numerous different transcripts and to identify functionally 
associated genes, such as signaling m olecules and their corresponding 
receptors, components of specific signal transduction pathways, transcription 
factors and their target genes, and many others. In this manner it would be 
possible to rapidly and quantitively determine the comprehensive gene 
expression profile of any given sample and to systematically correlate this 
data with previously obtained data, thereby allowing for the efficient 
characterization of novel transcripts. In combination with more specific 
methods for the systematic manipulation of gene expression (Spradling et 
al., 1995) as well as strategies for the systematic analysis of protein 
phosphorylation and glycosylation, this system could over the longer term 
enable the elucidation of the molecular mechanisms by which cells process 
and store information.
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Figure 1. Gene Identification by Boolean Selection
For the rapid identification of transcripts specifically expressed in tissue A at timepoint X, 
Boolean selection involves two initial negative selections through the subtractive 
hybridizations 1 = {region A NOT region B} and 2 = (timepoint X NOT timepoint Y}. 
Here NOT is understood to mean "greater than by factor where n is dependent upon the 
ratio of driver cDNA to tracer cDNA. This is followed by one positive selection through the 
rescue hybridization 3 = {1 AND 2} = {(A NOT B) AND (X NOT Y)}. This allows for the 
enrichment of cDNAs common to both subtracted pools and enables the rapid selection of 
those cDNA clones that fulfill both criteria (region A NOT region B } and (timepoint X NOT 
timepoint Y}.
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Figure 2. cDNA Synthesis, Amplification, and Subtraction
After mRNA purification and cDNA synthesis, the cDNA is fragmented with 4-base 
restriction endonucleases, ligated to adaptors, and PCR amplified with adaptor-specific 
primers (biotinylated primers are used for the driver cDNA). Driver and tracer cDNAs are 
combined at the ratio 20:1, denatured and allowed to renature in an optimized hybridization 
buffer. Driver-tracer hybrids and excess driver cDNAs are removed with streptavidinylated 
magnetic beads and the remaining tracer cDNA is ream plified for the next round of 
subtraction.
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Figure 3. Subtraction and Rescue Hybridization Scheme
For the efficient enrichment of differentially expressed transcripts, the subtraction strategy 
was designed so as to remove all common transcripts, regardless of their original 
abundance. As each subtraction is essentially a normalization with regard to these conunon 
transcripts, repetitive use of the original driver cDNA does not efficiently remove weakly to 
moderately expressed transcripts, which increase in relative abundance after each round of 
subtraction. The efficient removal of these transcripts can therefore only be achieved with 
the use of driver cDNAs that have the same transcript abundance profile, which holds true 
for the corresponding cDNA pool of the opposite sample when serial subtractions are done 
in parallel. This is done by maintaining the sequential order of driver-tracer matches such 
that Ao was paired with Bq, A% with B%, A2 with B2 , and so on. The rescue hybridization is 
carried out with the final subtracted cDNA pool (Ag) as the target and another subtracted 
cDNA pool (Xô) as the bait (the bait cDNA pool is biotinylated and used to select identical 
amphcons from the target cDNA pool).
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Figure 4. Enrichment Efficiency of the Improved Subtraction Procedure
In order to test the degree of enrichment of differentially regulated transcripts as provided by 
the improved subtraction prodecure, the enriched cDNA pools after the final round of 
subtractions were used as hybridization probes against all cDNA pools after each round of 
subtraction. Depicted above are the slot blot results obtained by carrying out these 
hybridizations using as probes the EN6 pool (right panel) and the NE^ pool (left panel). In 
each panel the right column of slots contains 1 pg each of ENq, E N |, ENo, ., and ENg in 
descending order, and the left column of slots contains 1 pg each of NEq, N Ei, NE2, ..., 
and NE6, also in descending order. No cross-hybridization is seen between the two final 
pools ENô and NE^ , indicating that nearly all common cDNAs were efficiently removed. 
The increased level in expression of the enriched transcripts can be seen by comparing the 
signal intensities of the two original cDNA pools ENq and NEq for each probe.
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Figure 5. Quantification of Enrichment and Subtraction Efficiencies 
For the quantitative assessment of the subtraction results depicted in Figure 4, the signal 
intensities of all target cDNA pools were determined for each probe using quantitative 
autoradiography. The y-axis of each plot represents arbitrary units for the determination of 
relative signal intensities, and the x-axis represents the 7 different cDNA pools of one sample 
after each round of subtraction (ENq-ô, for example). The two lower panels have 10-fold 
lower y-axis values in order to depict the little remaining cross-hybridization between each 
probe and the cDNA pools of the opposite sample.
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Figure 6. Quantification of Expression Levels of Selected Clones
The actual differential expression of the first 24 clones was determined by using these cDNA 
fragments as hybridization probes with slot blots containing Ipg each of the original cDNA 
pools (E, N, and D represent embryonic, normal adult, and deafferented adult superior 
colliculus, respectively). Shown above and on the previous page are only those 14 clones 
that were upregulated in both embryonic and deafferented SC (clones EN7-12 and EN7-13 
were identical, therefore only one is shown), The remaining 10 clones were only 
upregulated in deafferented SC as compared to normal adult SC (data not shown) and were 
not analyzed further. The 14 clones that fulfilled both selection criteria were sequenced and 
the putative sequence identification determined by BLAST searches (on both DNA and 
protein level) in all accessible electronic sequence databases.
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Figure 7. EN7-10: Sequence Homologies within the EGF Domain
The amino acid sequence of the EGF domain of clone EN7-10 was compared to that of other 
EGF superfamily members. This comparison was limited to the sequence between the distal 
and proximal cysteines of the six-cysteine motif that makes up most of the EGF domain. 
Abbreviations are: TGFa (transforming growth factor a), HB-EGF (heparin-binding EGF- 
like growth factor), SDGF (Schwannoma-derived growth factor), VGF (Vaccinia virus 
growth factor), and EGF (epidermal growth factor). The sequence shown for the 
neuregulins is the consensus sequence of several different splice variants (heregulins, glial 
growth factors, neu differentiation factor (NDF), and acetylcholine receptor-inducing activity 
(ARIA)).
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Figure 8. EN7-10: Sequence Homologies within the Follistatin Domains
The amino acid sequence of the two follistatin domains of the human homolog of clone EN7- 
10 was compared to those of follistatin and agrin. This comparison was limited to the 
sequence between the distal and proximal cysteines of the ten-cysteine motif that makes up 
most of the follistatin domain. Shown here is only one of the nine follistatin domains of 
agrin; the two follistatin domains of the human EN7-10 homolog are shown in sequential 
order. Conserved cysteines are depicted in pink, other residues conserved between all four 
domains are shown in green, and additional residues only eonserved in two or three of these 
domains are shown in black.
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Figure 9. Structural Comparison of EGF Superfamily Members
The overall structure of the human homolog of clone EN7-10 was compared with those of 
the EGF family of transmembrane growth factors and the neuregulins. Abbreviations are: 
T G F a (transforming growth factor a ), HB-EGF (heparin-binding EGF-like growth factor), 
SDGF (Schwannoma-derived growth factor), VGF (Vaccinia virus growth factor), and EGF 
(epidermal growth factor). The structure shown for the neuregulins is only of several 
different splice variants (heregulins, glial growth factors, neu differentiation factor (NDF), 
and acetylcholine receptor-inducing activity (ARIA)), yet most of the other variants are 
essentially similar with respect to the overall structure.
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